Finance

Lists
4009:TADAWUL
Middle East Healthcare Company SJSC
SAR 33.08
+0.36%
(+0.12) 1D
Sep 1, 3:17:51 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4009...
Open
SAR 32.94
High
SAR 33.50
Low
SAR 32.76
Mkt. cap
3.04B
Avg. vol.
371.30K
Volume
740.65K
Dividend
1.51%
Quarterly dividend
SAR 0.12
Ex-dividend date
Jul 8, 2026
P/E ratio
22.04
52-wk high
SAR 59.20
52-wk low
SAR 28.66
EPS
SAR 1.50
Shares outstanding
41.70M
No. of employees
4K
Open
SAR 32.94
High
SAR 33.50
Low
SAR 32.76
Mkt. cap
3.04B
Avg. vol.
371.30K
Volume
740.65K
Dividend
1.51%
Quarterly dividend
SAR 0.12
Ex-dividend date
Jul 8, 2026
P/E ratio
22.04
52-wk high
SAR 59.20
52-wk low
SAR 28.66
EPS
SAR 1.50
Shares outstanding
41.70M
No. of employees
4K
About Middle East Healthcare Company SJSC
CEO-
Employees4.32K
Founded1988
Headquarters-
SectorHealth care provider
Websitesaudigermanhealth.com
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
768.97M
808.79M
765.23M
845.52M
Cost of goods sold
485.02M
538.27M
503.19M
579.01M
Cost of revenue
485.02M
538.27M
503.19M
579.01M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
196.51M
183.55M
179.77M
178.16M
Operating expense
196.51M
183.55M
174.01M
175.65M
Total operating expenses
681.53M
721.82M
677.20M
754.66M
Operating income
87.44M
86.97M
88.04M
90.86M
Other non operating income
14.53M
1.66M
-
-
EBT including unusual items
51.87M
34.00M
37.76M
41.78M
EBT excluding unusual items
51.87M
35.28M
37.98M
41.78M
Income tax expense
8.75M
-3.32M
4.92M
5.39M
Effective tax rate
16.88%
-9.76%
13.03%
12.89%
Other operating expenses
-
-
-5.76M
-5.87M
Net income
40.29M
37.79M
33.47M
34.35M
Net profit margin
5.24%
4.67%
4.37%
4.06%
Earnings per share
0.44
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-48.00M
-42.09M
-43.08M
-42.22M
Net interest expenses
-48.00M
-42.09M
-43.08M
-42.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
145.44M
133.46M
146.75M
140.90M
Gain or loss from assets sale
90.98K
1.27M
-163.97K
383.71K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps